Lifecore Biomedical, Inc. De (LFCR) Long-Term Deferred Tax (2015 - 2018)

Lifecore Biomedical's Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $17.5 million for Q2 2018.

• In Q2 2018, Long-Term Deferred Tax fell 28.87% year-over-year to $17.5 million; the TTM figure through May 2018 stood at $17.5 million (down 28.87% YoY), while the FY2018 annual figure was $17.5 million, down 28.87% from the prior year.
• Long-Term Deferred Tax was $17.5 million for Q2 2018 at Lifecore Biomedical, down from $24.6 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $32.2 million in Q2 2015 to a low of $17.5 million in Q2 2018.
• Historically, Long-Term Deferred Tax has averaged $24.2 million across 4 years, with a median of $23.5 million in 2016.
• The sharpest annual moves came in 2016 and 2017: Long-Term Deferred Tax plunged 30.37% in 2016, then increased 9.53% in 2017.
• A 4-year view of Long-Term Deferred Tax shows it stood at $32.2 million in 2015, then slumped by 30.37% to $22.4 million in 2016, then advanced by 9.53% to $24.6 million in 2017, then slipped by 28.87% to $17.5 million in 2018.
• The last three Long-Term Deferred Tax figures came in at $17.5 million (Q2 2018), $24.6 million (Q2 2017), and $22.4 million (Q2 2016), per Business Quant data.